OncoDiag
Évreux
About OncoDiag
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Mar 2021)
- Website: oncodiag.fr
- Phone: +33 (0)2 27 34 35 52
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/oncodiag-109270 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.